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Abstract
Background: Necrotizing fasciitis (NF) is a rapidly progressive and life-threatening infection. This study aimed to
investigate the clinical characteristics and mortality- associated factors in diabetic patients.
Methods: Detailed clinical information of 165 NF cases was retrospectively collected and analyzed in National
Taiwan University Hospital between January 1997 and February 2013. We documented and compared the clinical
features according to the presence of underlying diabetes mellitus, and we identified risk factors associated with
mortality.
Results: There were 84 patients (51 %) with diabetes. The overall case fatality rate was 29.7 %, and we found no
significant difference between the patients with or without diabetes. Compared with the nondiabetic patients,
diabetic patients were older and exhibited higher serum levels of glucose and potassium on admission.
Polymicrobial infection and monomicrobial NF caused by Klebsiella pneumoniae were also more frequently
associated with diabetic patients. Moreover, diabetic NF patients exhibit a significantly higher chance of limb loss
during hospitalization. In the combined diabetic and nondiabetic cohort, a high serum level of potassium (odds
ratio, 2.2; 95 % confidence interval, 1.2 to 4.02; P = 0.011) on admission was independently associated with mortality,
whereas positive blood culture on admission was associated with mortality in the diabetic cohort (odds ratio, 7.36;
95 % confidence interval, 1.66 to 32.54; P = 0.009).
Conclusions: Diabetic patients are more susceptible to NF caused by polymicrobial infection or K. pneumoniae, and
they are more likely to receive limb amputation for infection control. Bacteraemia on admission is a significant risk
factor for mortality in diabetic NF patients.
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Background
Necrotizing fasciitis (NF) has been defined as a severe
soft-tissue infection that causes extensive necrosis of
subcutaneous tissue and fascia, relatively sparing the
muscle and skin tissue [1]. As the disease progresses,
thrombosis of the affected cutaneous perforators subse-
quently devascularizes the overlying skin, causing skin
necrosis and haemorrhagic bullae to form. Bacteraemia
and sepsis invariably develop when the infection is well
established [2]. Despite aggressive treatment, the reported
case fatality rate for NF remains high at a cumulative rate
up to 34 % [3]. In the literature, most NF patients have
preexisting medical conditions, including gout, periph-
eral arterial occlusive disease, myelodysplastic syn-
drome, liver cirrhosis, and other immunosuppressive
conditions [4–7]. Diabetes mellitus (DM) has been
reported to be a common underlying disease in NF
patients, accounting for 44.5–72.3 % in various series
[1, 6, 8, 9]. Diabetic patients exhibit impaired cutaneous
wound healing and increased susceptibility to infection,
which may affect the course of soft-tissue infections
[10]. It is thus reasonable to speculate that this chronic,
debilitating disease contributes to a more serious
nature of NF.
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Based on bacterial culture results, NF is classified
into the following categories: type I, which consists of
synergistic polymicrobial infection; type II, representing
infections caused by group A Streptococcus alone or
combined with Staphylococcus; and type III, which
comprises infections caused by Vibrio species [11].
However, recent studies have revealed emerging mono-
microbial pathogens of NF, such as methicillin-resistant
Staphylococcus aureus (MRSA), indicating that the
bacteriology of the causative agent of NF is constantly
changing [12–14]. Moreover, certain causative agents of
NF, including Klebsiella pneumonia, are more likely to
involve underlying immunocompromising conditions
[8]. Therefore, exploration of the bacteriology of NF
patients with specific underlying conditions is of great
value in guiding the empirical antimicrobial therapy.
Although previous studies have attempted to investi-
gate the clinical characteristics of NF in diabetic patients
[15–17], little is known about the microbiology profile
and the mortality-associated factors of these patients.
Hence, this study was designed to compare the clinical
features, including patient age, comorbidities, extent of
infection, microbiology, laboratory markers, and time to
surgery, in diabetic and nondiabetic NF patients, and we




Using the International Classification of Diseases (ICD)-9
code of NF (728.86), we identified all consecutive NF cases
confirmed by surgery between January 1997 and February
2013 in National Taiwan University Hospital, which is a
university-affiliated medical centre featuring a 2200-bed
capacity. The hospital provides both primary and tertiary
referral care in Northern Taiwan. The study procedures
were approved by a Research Ethics Committee of
National Taiwan University Hospital (201310011RIND).
The ethics committee waived the need for obtaining con-
sent from the patients, and the patient data from the data-
set were anonymized for further analysis.
Definition of clinical variables
A definitive diagnosis of NF was based on the intraop-
erative and histopathological findings. Operative find-
ings are characterised by a lack of resistance to blunt
dissection of the normally adherent fascia and the
presence of necrotic fascia with purulent malodorous
discharge. Diagnosis of diabetes was made based on
clinical history and past laboratory tests according to
the 2010 American Diabetes Association criteria [18].
Data on the causal microorganisms were collected by
reviewing the microbiological reports of wound and/or
blood culture samples that were obtained before or at the
time of operation. Other clinical variables were defined ac-
cording to the current literature (Table 1) [8, 19].
Treatment protocol
The treatment protocol included emergent radical
surgery, broad-spectrum antibiotic therapy, aggressive
resuscitation, and soft tissue reconstruction. Emergent
surgery with endotracheal tube insertion and general
anesthesia was performed in all patients. Empirical
antibiotic therapy with oxacillin and a third-generation
cephalosporin was usually prescribed upon suspicion of
NF. The antibiotic regimen was adjusted when the
culture results were available. Moreover, aggressive
resuscitation, including intravenous fluid and inotropic
agents, were given to all patients to maintain mean
arterial pressure above 65 mmHg [13].
Collection of clinical data
We used a computerised data collection form to sys-
tematically collect the following information from the
medical records of NF patients:
(1)clinical manifestations, including the infection
site(s), local findings, severity of sepsis syndrome,
and laboratory data on admission;
(2) underlying medical conditions, including DM,
malignancy, liver cirrhosis, use of
immunosuppressants, and chronic renal failure;
(3) laboratory results in the emergency room or within
24 h after admission; haemoglobin, white blood cell
count, platelet count, sodium, and potassium were
expressed as continuous variables, and C-reactive
protein and glucose were dichotomised using a
cut-off point that was based on clinical experience
and previous reports [19];
(4) treatments and outcomes, including time to surgery,
surgical interventions, limb loss, hospital stay, and
in-hospital mortality.
Statistical analysis
The data were summarized using descriptive statistics.
For categorical variables, descriptive analysis were based
on percentages and frequencies, and the continuous var-
iables are expressed as the mean and standard deviation
(SD). For between-group comparison, the Student’s t test
was used for continuous data and the chi-square test or
Fisher’s exact test was used for categorical data. The po-
tential risk factors for mortality were examined in all of
the NF patients, diabetic NF patients, and nondiabetic
NF patients. Logistic regression was performed to pro-
duce odds ratios (ORs) with 95 % confidence intervals
(CIs). Multivariate logistic regression was used in asses-
sing risk factors by adding forward substitution factors
identified as significant in the univariate analysis (P <0.05).
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All reported P values were two-tailed and P <0.05 indi-
cated statistical significance in each analysis. The statistical




We identified 165 NF patients that met the inclusion cri-
teria. The mean age was 58.8 years, and 110 patients
were men (67 %) and 55 patients were women (33 %).
Underlying chronic diseases, including DM (n = 84,
51 %), hypertension (n = 59, 36 %), heart disease (n = 39,
24 %), chronic kidney disease (n = 29, 18 %), and liver
cirrhosis (n = 22, 13 %) were common. The infection
most commonly involved the lower limbs (n = 111,
67 %), followed by the trunk (n = 21, 13 %), and the
upper limbs (n = 17, 10 %). Seventy-eight patients (47 %)
reported a preceding trauma or injury history at the in-
fection site. Antibiotic susceptibility data of the causative
agents were available in 81 patients, and 19 of them
(23.5 %) were found to receive inappropriate empirical
antibiotics. During hospitalisation, the NF patients
underwent an average of 2.7 ± 1.8 surgical debridements.
Major limb amputation was performed in 35 patients
(21 %), and 49 patients died during hospitalization, yield-
ing a case fatality rate of 29.7 %.
Comparison of diabetic and nondiabetic NF patients
Among the 165 NF cases, 121 (73.3 %) were monomicro-
bial, 30 (18.2 %) were polymicrobial, and 14 (8.5 %) were
culture negative (Table 2). The most common pathogens
of monomicrobial NF were K. pneumoniae (n = 17), group
A Streptococcus (n = 16), and MRSA (n = 12). Causative
agents of NF in the diabetic patients were more likely to
be polymicrobial (P < 0.01), whereas significantly more
monomicrobial NF infections caused by K. pneumoniae
developed in diabetic patients (DM, 13 cases vs. non-DM,
4 cases, P < 0.05).
We classified the NF patients into DM and non-DM
cohorts and compared their clinical characteristics
(Table 3). Relative to the nondiabetic patients, the
diabetic patients were significantly older (P < 0.05) and
presented with significantly higher serum levels of glu-
cose and potassium upon admission (P < 0.01). Although
the case fatality rate of NF was comparable between the
DM and non-DM cohorts (DM, 28.6 % vs. non-DM,
30.9 %, P = 0.747), the limb amputation rate was signifi-
cantly higher among the diabetic NF patients (DM,
28.6 % vs. non-DM, 13.6 %, P <0.05).
Risk factors for mortality
We also compared the clinical characteristics of the
survivors and non-survivors among NF patients
(Table 4). Then mortality-associated risk factors were
determined in diabetic and nondiabetic NF patients as
a combined cohort, and then separately. No signifi-
cant differences in the parameters of age, gender, site
of involvement, types of NF infection, appropriate
empirical antibiotic use, and time to first surgical
intervention were observed between survivors and
non-survivors in either the combined or respective
cohort. For all of the NF patients, clinical signs of
Table 1 Definitions of clinical parameters
Variable Definition
Diabetes mellitus The diagnosis is based on one of four abnormalities outlined by American Diabetes Association, 2010: glycated
hemoglobin (A1C) ≥6.5 %, fasting plasma glucose (FPG) ≥126 mg/dl, random plasma glucose ≥200 mg/dl with symptoms,
or two-hour plasma glucose ≥200 mg/dl during an oral glucose tolerance test (OGTT)
Functional status Patient requiring no, partial or totally dependent assistance from another person for activities of daily living before surgery
Hypertension Patient with elevated blood pressure requiring medication
Chronic renal
failure
Patient with a rising creatinine >3 mg/dl or a decreased glomerular filtration rate of less than 60 ml/min/1.73 m2 for 3 or more
months
Liver cirrhosis Diagnosis based on clinical, laboratory and echographic findings
SIRS Includes the presence of two or more of the following: temperature >38 °C or <36 °C, heart rate >90 bpm, respiratory rate >20
breaths/min or PaCO2 < 32 mm/Hg, WBC >12,000/mm
3 or <4000/mm3, or >10 % immature (band) forms, anion gap acidosis
Septic shock Includes sepsis and documented organ and/or circulatory dysfunction
ASA score 1 = normal healthy patient
2 = patient with mild systemic disease
3 = patient with severe systemic disease
4 = patient with severe systemic disease that is a constant threat to life
5 =moribund patient who is not expected to survive without the operation
Limb loss Amputation of the lower or upper limb above the ankle or the wrist, respectively.
SIRS systemic inflammatory response syndrome, ASA American Society of Anesthesiologists
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dyspnea and hypotension upon admission were asso-
ciated with mortality according to a univariate ana-
lysis. Moreover, initial laboratory data revealing a low
platelet count, a high blood level of potassium, and a
positive blood culture were also mortality-associated
factors. According to a multivariate analysis, only a
high blood level of potassium upon admission was
independently associated with mortality (Table 5).
In the cohort of 84 diabetic NF patients, clinical signs
of dyspnea and hypotension upon admission were asso-
ciated with mortality according to a univariate analysis.
Moreover, initial laboratory data revealing a higher level
of potassium in the blood and a positive blood culture
were also mortality-associated factors. According to a
multivariate analysis, only a positive blood culture upon
admission was independently associated with mortality
in diabetic NF patients (Table 6).
According to univariate analysis of 81 nondiabetic
NF patients, an independent functional status and the
presence of pus at infection sites were inversely asso-
ciated with mortality, whereas clinical presentation
with systemic inflammatory response syndrome (SIRS)
and a low platelet count upon admission were associ-
ated with mortality. With further multivariate analysis,
an independent functional status and the presence of
pus at infection sites were independent factors in-
versely associated with mortality, and the presence of
SIRS upon admission was associated with mortality
(Table 7).
Discussion
NF is likely to develop in immunocompromised patients
with underlying medical conditions, such as alcohol abuse,













Group A Streptococcus 12 (7.3) 3 (3.6) 9 (11.1) 0.076
Group B Streptococcus 4 (2.4) 2 (2.4) 2 (2.5) 1.0
Staphyloccocus aureus
MRSA 14 (8.5) 6 (7.1) 8 (9.9) 0.529
MSSA 12 (7.3) 5 (6.0) 7 (8.6) 0.561
Aeromonas hydrophilia 7 (4.2) 2 (2.4) 5 (6.2) 0.271
Vibrio vulnificus 9 (5.5) 4 (4.8) 5 (6.2) 0.737








4 (2.4) 0 (0) 4 (4.9) 0.056
Serratia
marcescens
4 (2.4) 2 (2.4) 2 (2.5) 1.0












14 (8.5) 7 (8.3) 7 (8.6) 0.943
Total 165 84 81
DM diabetes mellitus, MRSA methicillin-resistant Staphylococcus aureus, MSSA
methicillin-sensitive Staphylococcus aureus
Table 3 Clinical characteristics of the non-diabetic and diabetic
cohorts among necrotizing fasciitis patients
Variable DM (n = 84) Non-DM
(n = 81)
P value
Age 61.5 ± 10.6 56 ± 22.2 0.045
Male gender 58(69.1) 52(64.2) 0.509
American Society of Anaesthesiologists (ASA) score





Hypertension 35(42.2) 24(29.6) 0.094
Chronic renal failure 19(22.6) 10(12.4) 0.083
Liver cirrhosis 12(14.3) 10(12.4) 0.714
Malignancy 6(7.1) 8(9.9) 0.529
Immunosuppresant medication 7(8.3) 8(9.9) 0.730
Admission lab data
Hemoglobin (mg/dl) 10.4 ± 2.5 10.8 ± 2.5 0.321
Leukocyte count (103/mm3) 11.1 ± 9.9 10.5 ± 11.8 0.767
Platelet count (103/mm3) 188.8 ± 129.5 160.7 ± 109.3 0.167
C-reactive protein > 10 mg/dla 43(75.4) 44(83.0) 0.329
Glucose > 110 mg/dlb 41(85.4) 17(48.6) <0.001
Potassium (mEq/l) 4.4 ± 1.1 4.0 ± 0.8 0.010
Positive blood culturec 28(41.8) 27(49.1) 0.420
Location of infection
body 10(11.9) 11(13.6) 0.651
head and neck 3(3.6) 1(1.2)
upper limb 9(10.7) 8(9.9)
lower limb 54(64.3) 57(70.4)
multiple sites 8(9.5) 4(4.9)
Time to surgery <12 h 43(51.2) 44(54.3) 0.687
ICU stay (day) 9.3 ± 10.8 9.8 ± 12.1 0.793
Hospital stay (day) 39.1 ± 28.6 41.1 ± 38.4 0.712
Limb loss 24(28.6) 11(13.6) 0.019
Mortality 24(28.6) 25(30.9) 0.747
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malignancy, chronic cardiac and renal disease, intravenous
drug usage, immunosuppressive therapy, and malnutrition
[9]. Diabetes is a disorder that adversely affects the
immune system, thus representing a common underlying
disease in NF patients. In our series, the diabetic NF
patients were significantly older than the nondiabetic
patients at the onset of NF. Moreover, diabetic patients
were significantly more likely than nondiabetic patients to
exhibit a high blood level of glucose upon admission.
Insulin therapy for glycaemic control at a target blood
glucose level of 140 to 200 mg/dl has been suggested in
critically ill patients [20]. Therefore, the high incidence of
hyperglycaemia observed upon admission among diabetic
NF patients warrants initiating monitor of blood glu-
cose level and glycaemic control immediately after
hospitalisation.
Traditionally, type 1 (polymicrobial) NF was the
most common type of infection, emphasizing the syn-
ergetic effects of multiple pathogens [2, 3]. Analysis
of the causative agents of NF revealed that signifi-
cantly more diabetic patients exhibited polymicrobial
infections than did nondiabetic patients, possibly
reflecting the susceptibility of diabetic patients to
multiple pathogens [21]. However, single organism in-
fection accounted for the majority of NF (74 %) in
this study, which is in line with the recent studies
demonstrating a trend of increasing monomicrobial
NF [8, 14, 22]. Among the monomicrobial NF cases,
we observed significantly more K. pneumoniae-related
infections in the DM group than in the non-DM
group. We previously described K. pneumoniae as a
common pathogen of monomicrobial NF in Taiwan,
particularly in patients with underlying host immuno-
compromising conditions [8]. The present study
further emphasized the importance of recognizing
monomicrobial NF caused by K. pneumoniae as a
common entity of NF in diabetic patients. Therefore,
initial empirical antimicrobial agents for NF should be
considered depending on the presence of underlying
diabetes.
In our series, a non-significant difference in case
fatality rate between diabetic and nondiabetic pa-
tients was observed. This is in line with the finding
of previous studies that DM combined with other co-
morbidities was associated with an increased risk of
death, but DM alone was not a risk factor for mor-
tality [4, 17]. Also consistent with many previous
studies, NF was most commonly involved in the
lower limbs in this study [6, 8, 9]. Moreover, we
found that significantly more diabetic patients than
nondiabetic patients experienced limb loss during the
treatment course. Diabetic patients are well known to
be afflicted with foot problems caused by neuropathy
and microvascular disease, which render limb preser-
vation more difficult in the presence of a superim-
posed NF infection. Amputation typically requires
less time than radical debridement of the necrotic
soft tissue, and requires few, if any, reconstructive
procedures [4]. Although major limb amputation de-
prives the amputee of motional dexterity and should
Table 4 Clinical characteristics of the survivors and







Age 57.8 ± 17.9 61 ± 16.4 0.297
Male gender 75(64.7) 35(71.4) 0.399
American Society of Anaesthesiologists (ASA) score
1 13(11.2) 5(10.2) 0.268
2 33(28. 5) 10(20.4)
3 50(43.1) 19(38. 8)
4 20(17.2) 15(30.6)
Pre-existing medical conditions
Diabetes mellitus 60(51.7) 24(49.0) 0.747
Hypertension 39(33.6) 20(41. 7) 0.329
Chronic renal failure 17(14.7) 12(24.5) 0.129
Liver cirrhosis 13(11.2) 9(18.4) 0.216





Hemoglobin (mg/dl) 10.8 ± 2.4 10.1 ± 2.6 0.135
Leukocyte count (103/mm3) 11.3 ± 11.3 9.7 ± 9.9 0.3777
Platelet count (103/mm3) 193.7 ±
128.8
135.2 ± 89.0 0.0021
C-reactive protein > 10 mg/dla 58(79. 5) 29(78.4) 0896
Glucose > 110 mg/dlb 39(65) 19(82.61) 0.356
Potassium (mEq/l) 4.0 ± 0.9 4.5 ± 1.2 0.034
Positive blood culturec 33(38.82) 22(59.46) 0.035
Location of infection
body 9(7.8) 12(24.5) 0.025
head and neck 3(2.6) 1(2.0)
upper limb 10(8.6) 7(14.3)
lower limb 84(72.4) 27(55.1)
multiple sites 10(8.6) 2(4.1)
Time to surgery <12 h 62(54.39) 25(54.35) 0.531
ICU stay (day) 9.5 ± 12.1 9.5 ± 10.4 0.977
Hospital stay (day) 51.7 ± 33.4 13.6 ± 14.4 <.0001
Limb loss 28(24.1) 7(14.3) 0.157
In Tables 3 and 4, data presented as mean ± standard deviation for continuous
data or number (%) for categorical data
adata derived from 103 of the 165 cases
bdata derived from 72 of the 165 cases
cdata derived from 114 of the 165 cases
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be avoided whenever possible, NF is one of the few
exceptions for which this extreme procedure should
be considered to save lives [23].
Multiple patient- and treatment-related risk factors
for NF-associated mortality have been described
[24–27]. However, the identified risk factors among
various studies exhibited some discrepancies. For
example, some studies linked poor outcomes to de-
lays in surgical management [6, 28], whereas other
studies, similar to this one, found delayed surgical
management did not significantly impact mortality
[19, 27]. The discrepancies among different studies
reflect the diversity of the populations included and
the variables studied. In this study, we focused on
factors that can be easily identified at the initial
presentation of NF patients.
In all NF cases in this series, mortality was associated
with a high level of serum potassium on admission.
Electrolyte imbalance is a common clinical presentation of
NF [6, 29], and Ogilvie et al. also showed an
increased risk of mortality in NF patients with ele-
vated potassium levels [30]. The elevated serum po-
tassium level on admission may reflect acute renal
impairment. Unfortunately, serum creatinine level was
not collected in our database so the association be-
tween hyperkalemia and renal impairment could not
be confirmed. Nonetheless, our finding still highlights
the importance of the supportive care with fluid and
electrolyte management in NF patients. Further sub-
group analysis revealed that a positive blood culture
upon admission was associated with mortality in dia-
betic NF patients. Bacteraemia frequently causes sep-
sis, which is the typical cause of death in NF patients.
As virulent organisms and toxins are released into
the bloodstream from severely infected soft tissue, a
systemic toxic reaction is initiated, resulting in
hypotension, disseminated intravascular coagulation,
and eventually multiorgan failure.
Table 5 Univariate & multivariate analysis of risk factors for mortality in all necrotizing fasciitis patients
Variable Univariate analysis Multivariate analysis
OR(95 % CI) P value OR(95 % CI) P value
Age 1.01(0.99,1.03) 0.3
Male gender 1.37(0.66,2.83) 0.4
Functional status
Partially dependent 1 -
Totally dependent 0.79(0.25,2.52) 0.69
Totally independent 0.79(0.38,1.61) 0.51
Underlying medical conditions
DM 0.90(0.46,1.75) 0.75
Chronic renal failure 1.89(0.82,4.33) 0.13
Immunosuppresant medication 1.66(0.56,4.94) 0.36
Clinical presentation at admission
Consciousness disturbance 1.77(0.88,3.56) 0.11
Temperature > 38 °C 1.58(0.77,3.22) 0.21
Dyspnea 2.68(1.32,5.45) 0.007 2.29(0.81,6.43) 0.117
Systolic BP < 90 mmHg 2.03(1.02,4.06) 0.045 1.14(0.4,3.2) 0.810
SIRS 2.08(0.73,5.88) 0.17
Pus at infection site 0.73(0.31,1.68) 0.45
Admission lab data
Hemoglobulin (mg/dl) 0.90(0.78,1.04) 0.14
Leukocyte (103/mm3) 0.99(0.95,1.02) 0.38
Platelet (103/mm3) 0.995(0.99,0.999) 0.008 1(0.99,1) 0.056
Potassium (mEq/l) 1.57(1.06,2.31) 0.023 2.2(1.2,4.02) 0.011
Positive blood culture 2.31(1.05,5.08) 0.037 1.95(0.71,5.38) 0.197
Time to surgery <12 h 0.83(0.41,1.68) 0.598
(n = 165)
OR odds ratio, CI confidence interval, SIRS systemic inflammatory response syndrome
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The presence of SIRS upon admission was also
identified as a mortality- associated factor in nondia-
betic NF patients. Moreover, a completely independ-
ent functional status and the presence of pus at the
infection site upon admission were associated with a
more favourable chance of survival in the non-DM
group. The functional status reflects the general phys-
ical condition of a person, thus an independent func-
tional status can reasonably serves as a predictor of
better outcome. However, the association between the
presence of pus upon admission and a favourable out-
come is intriguing. Similarly, a previous study identi-
fied the presence of hemorrhagic bullae on admission
as an independent negative predictor of mortality in
NF patients [22]. Diagnosis of NF at an early stage is
often difficult and depends on a high index of suspi-
cion because early cutaneous findings, including
edema, erythema, and local anaesthesia, are typically
nonspecific [6, 29]. Therefore, we speculated that ob-
vious cutaneous manifestations, such as pus or bullae
formation, at the infection sites may prompt surgical
consultation, necessitating early diagnosis and imme-
diate surgical intervention, which are crucial for the
survival of NF patients.
The limitations of this study are attributable to the
retrospective study design and possible inaccuracy of the
information retrieved from the medical records or the
possible misinterpretation of this information. However,
we attempted to address these problems by setting clear
definition for variables prior to data collection. We also
excluded variables without sufficient data from further
statistical analysis, such as arterial blood gas and serum
albumin level. Moreover, not all of the factors related to
NF prognosis, such as nutrition, surgical dexterity, and
postoperative wound care, could be considered. To
enhance our understanding of NF, a prospective registry
for all NF patients confirmed according to surgery will
be a valuable tool [9]. It may include standard recording
of underlying diseases, presenting symptoms and signs,
clinical photography, thorough laboratory data of blood
samples, imaging and bacteriological studies, and treat-
ment course.
Table 6 Univariate & multivariate analysis of risk factors for mortality in diabetic necrotizing fasciitis patients
Variable Univariate analysis Multivariate analysis
OR(95 % CI) P value OR(95 % CI) P value
Age 0.98(0.93,1.02) 0.34
Male gender 2.05(0.67,6.26) 0.21
Functional status
Partially dependent 1 -
Totally dependent 2.72(0.5,14.72) 0.25
Totally independent 1.81(0.65,5.07) 0.26
Underlying medical conditions
Chronic renal failure 1.65(0.56,4.87) 0.37
Immunosuppresant medication 3.80(0.78,18.47) 0.10
Clinical presentation at admission
Consciousness disturbance 1.69(0.64,4.45) 0.29
Temperature > 38 °C 1.87(0.68,5.18) 0.23
Dyspnea 3.50(1.24,9.89) 0.018 4.19(0.98,17.91) 0.053
Systolic BP < 90 mmHg 2.89(1.05,7.96) 0.040 1.81(0.45,7.21) 0.403
SIRS 0.78(0.21,2.88) 0.70
Pus at infection site 1.75(0.59,5.21) 0.31
Admission lab data
Hemoglobulin (mg/dl) 0.86(0.69,1.06) 0.16
Leukocyte (103/mm3) 1.01(0.96,1.06) 0.81
Platelet (103/mm3) 0.996(0.99,1.001) 0.13
Potassium (mEq/l) 1.84(1.08,3.15) 0.025 1.65(0.84,3.24) 0.147
Positive blood culture 4.57(1.52,13.78) 0.007 7.36(1.66,32.54) 0.009
(n = 84)
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Conclusions
Diabetes is a common predisposing medical condition
of NF, and it is associated with a significantly higher
chance of limb loss. Relative to nondiabetic patients,
diabetic NF patients were older and presented with a
higher serum level of glucose and potassium. More-
over, diabetic NF patients were more susceptible to
polymicrobial and monomicrobial K. pneumoniae in-
fections, which should be considered when choosing
empirical antibiotics for these patients. Bacteraemia
on admission is significant risk factor for mortality in
NF patients with diabetes. We also identified several
independent risk factors for mortality in nondiabetic
NF patients. These information can be applied in pre-
dicting outcomes and used to guide the treatment of
NF patients according to the presence of underlying
diabetes. This study thus provides an impetus for
further clinical research to assess the impact of modi-
fication of these identified factors on the subsequent
clinical outcomes of both diabetic and nondiabetic
NF patients.
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Variable Univariate analysis Multivariate analysis
OR(95 % CI) P value OR(95 % CI) P value
Age 1.02(1.00,1.04) 0.1
Male gender 0.99(0.37,2.64) 0.98
Functional status
Partially dependent 1 -
Totally dependent 0.22(0.04,1.25) 0.09 0.23(0.03,2.09) 0.193
Totally independent 0.29(0.1,0.85) 0.025 0.16(0.04,0.74) 0.019
Underlying medical conditions
Chronic renal failure 2.55(0.67,9.77) 0.17
Immunosuppresant medication 0.73(0.14,3.87) 0.71
Clinical presentation at admission
Consciousness disturbance 1.97(0.70,5.56) 0.2
Temperature > 38 °C 1.40(0.50,3.90) 0.52
Dyspnea 2.15(0.80,5.76) 0.13
Systolic BP < 90 mmHg 1.45(0.56,3.78) 0.45
SIRS 8.21(1.01,66.85) 0.049 12.21(1.09,137.21) 0.043
Pus at infection site 0.22(0.05,1.03) 0.05 0.09(0.01,0.86) 0.037
Admission lab data
Hemoglobulin (mg/dl) 0.93(0.77,1.13) 0.45
Leukocyte (103/mm3) 0.97(0.93,1.02) 0.18
Platelet (103/mm3) 0.99(0.987,0.999) 0.021 0.997(0.99,1.004) 0.382
Potassium (mEq/l) 1.39(0.71,2.70) 0.34
Positive blood culture 1.05(0.33,3.37) 0.93
(n = 81)
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